HaEmek Medical Center is a hospital in the northern Israeli city of Afula. Located in the central part of the Jezreel Valley, the hospital is one in a network of hospitals owned and operated by Clalit Health Services, and is affiliated with the Technion's Rappaport Faculty of Medicine.

During the past decade, haemek MC conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 5 clinical trials were completed, i.e. on average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "haemek MC" #1 sponsor was "HaEmek Medical Center, Israel" with 20 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Augmedics" with 1 trials sponsored, "Beersheva Mental Health Center" with 1 trials sponsored and "Cyclo Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "haemek MC" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Stanley Medical Research Institute" with 1 trials as a collaborator, "Syqe Medical" with 1 trials as a collaborator and "Technion, Israel Institute of Technology" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "haemek MC" are "Sickle Cell Anemia" (4 trials), "Atopic Dermatitis" (3 trials), "Psoriasis" (3 trials), "Thalassemia" (3 trials) and "Iron Overload" (2 trials). Many other conditions were trialed in "haemek MC" in a lesser frequency.

Most popular intervention types in "haemek MC" are "Drug" (17 trials), "Device" (7 trials), "Other" (3 trials), "Procedure" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Baricitinib" (2 trials), "Mirikizumab" (2 trials), "Atropine" (1 trials) and "Bivalirudin" (1 trials). Other intervention names were less common.

The vast majority of trials in "haemek MC" are 27 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "haemek MC". 2 are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in haemek MC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in haemek MC, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 10 trials that are defined as “Not Applicable".